Yubo International Biotech Limited
YBGJ
$0.01
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.77% | 52.34% | 80.02% | -15.45% | 44.01% |
| Total Depreciation and Amortization | 4.72% | -9.92% | -1.96% | -4.09% | -63.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.20% | -54.20% | -80.20% | 1.55% | -- |
| Change in Net Operating Assets | 118.21% | -104.40% | 161.65% | -5.25% | -296.03% |
| Cash from Operations | 86.19% | -201.64% | 108.67% | -18.57% | -67.03% |
| Capital Expenditure | -- | -- | -67.20% | 67.20% | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -2.56% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -23.13% | 79.33% | -- |
| Total Debt Issued | -63.63% | 100.00% | -16.80% | 32.16% | 38.47% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -66.14% | 100.00% | -52.18% | -9.86% | 48.77% |
| Foreign Exchange rate Adjustments | 4.45% | 1,277.78% | -129.70% | 19.50% | 4.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -190.00% | 110.64% | 101.35% | -94.48% | -190.91% |